FIGURE

Fig. 3

ID

ZDB-FIG-240529-30

Publication

Chen et al., 2024 - Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

The metabolism and spatial signatures of wedelolactone (WEL) and demethylwedelolactone (DWEL) in zebrafish. (A) Metabolism pathway of WEL and the structural inferences of its metabolites. (B) Mass spectrometry (MS) images depicting the spatial distribution of WEL and its metabolites in zebrafish whole-body section. (C) Metabolism pathway of DWEL and the structural inferences of its metabolites. (D) MS images depicting the spatial distribution of DWEL and its metabolites in zebrafish. WEL-Sulf: sulfated wedelolactone; WEL-GlcA: glucuronidated wedelolactone; WEL-Sulf-GlcA: sulfated-glucuronidated wedelolactone; WEL-Sulf-Glc: sulfated-glucosidated wedelolactone; DWEL-Sulf: sulfated demethylwedelolactone; DWEL-GlcA: glucuronidated demethylwedelolactone; DWEL-Sulf-GlcA: sulfated-glucuronidated demethylwedelolactone; DWEL-Sulf-Glc: sulfated-glucosidated demethylwedelolactone; MWEL: methylated wedelolactone; MWEL-Sulf: methylated and sulfated wedelolactone; MWEL-GlcA: methylated and glucuronidated wedelolactone; MWEL-Sulf-GlcA: methylated, sulfated and glucuronidated wedelolactone; MWEL-Sulf-Glc: methylated, sulfated and glucosidated wedelolactone.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Pharm Anal